1. Home
  2. BOC vs BCYC Comparison

BOC vs BCYC Comparison

Compare BOC & BCYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOC
  • BCYC
  • Stock Information
  • Founded
  • BOC 2009
  • BCYC 2009
  • Country
  • BOC United States
  • BCYC United Kingdom
  • Employees
  • BOC N/A
  • BCYC N/A
  • Industry
  • BOC
  • BCYC Biotechnology: Pharmaceutical Preparations
  • Sector
  • BOC
  • BCYC Health Care
  • Exchange
  • BOC Nasdaq
  • BCYC Nasdaq
  • Market Cap
  • BOC 482.8M
  • BCYC 566.5M
  • IPO Year
  • BOC 2017
  • BCYC 2019
  • Fundamental
  • Price
  • BOC $14.70
  • BCYC $8.22
  • Analyst Decision
  • BOC Buy
  • BCYC Buy
  • Analyst Count
  • BOC 2
  • BCYC 10
  • Target Price
  • BOC $20.00
  • BCYC $25.00
  • AVG Volume (30 Days)
  • BOC 107.5K
  • BCYC 333.0K
  • Earning Date
  • BOC 05-14-2025
  • BCYC 05-01-2025
  • Dividend Yield
  • BOC N/A
  • BCYC N/A
  • EPS Growth
  • BOC N/A
  • BCYC N/A
  • EPS
  • BOC 0.03
  • BCYC N/A
  • Revenue
  • BOC $110,452,664.00
  • BCYC $25,722,000.00
  • Revenue This Year
  • BOC $9.66
  • BCYC N/A
  • Revenue Next Year
  • BOC $6.33
  • BCYC $1.83
  • P/E Ratio
  • BOC $546.31
  • BCYC N/A
  • Revenue Growth
  • BOC 11.58
  • BCYC N/A
  • 52 Week Low
  • BOC $12.41
  • BCYC $6.10
  • 52 Week High
  • BOC $16.20
  • BCYC $28.67
  • Technical
  • Relative Strength Index (RSI)
  • BOC 47.93
  • BCYC 49.16
  • Support Level
  • BOC $14.11
  • BCYC $8.00
  • Resistance Level
  • BOC $15.10
  • BCYC $8.73
  • Average True Range (ATR)
  • BOC 0.35
  • BCYC 0.48
  • MACD
  • BOC -0.01
  • BCYC 0.02
  • Stochastic Oscillator
  • BOC 37.50
  • BCYC 33.33

About BOC Boston Omaha Corporation

Boston Omaha Corp is a us-based company which invests in real estate. Its operations include its ownership of multiple billboards in Florida, Georgia, Wisconsin, and Alabama and equity method investments in several real estate companies. The company operates four separate lines of business, outdoor billboard advertising, the broadband services industry, the insurance industry, and the asset management industry. They generate revenue from outdoor advertising through the leasing of advertising space on billboards. It also generate revenue from commissions on surety bond sales and account for commissions and principally from internet services and is recognized on a straight-line basis over the term of the contract in the period the services are rendered.

About BCYC Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.

Share on Social Networks: